Covid-19 roundup: Po­lit­i­cal pres­sures at FDA con­tin­ue post-elec­tion; Med­ica­go takes GSK ad­ju­vant in­to its first PhII/III

Though the pres­i­den­tial elec­tion has come and gone, ten­sions be­tween the White House and gov­ern­ment health of­fi­cials re­main.

With the news out Mon­day that Pfiz­er …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER